The Chromosome Pathology Unit (CPU)was set up in 2010 to fulfill the need in the """"""""in house"""""""" laboratory FISH tests required to support clinical trials at NCI. FISH diagnostics will be an integral part of the Pathology molecular diagnostics currently offered by the Lab of Pathology. The sensitivity and specificity of FISH diagnostics was found to be near 100% in recent reports of CAP that puts them in front line among other available tests based on PCR and immunohistochemistry that have a long-known specificity problem. The Unit has been equipped as state-of-the art laboratory that includes a new Zeiss epifluorescence microscope with the ApoTome feature that allows FISH analysis and imaging of thick tissue sections, SKY-cube for spectral karyotyping - a modern tool for the detection of chromosomal translocations in cancer cells and various hereditary syndromes. All small equipment to measure the DNA quantity, run PCR to validate the FISH data, the CO2 incubator to grow cells were purchased as well. The developed/ validated tests include Her-2 amplification in Breast Cancer Patients, cmyc translocation in Burkitt, and Diffuse Large B Cell Lymphomas, 1p/19q deletion tests as prognostic and diagnostic markers for brain tumors, Bcl-2 translocation detection in Follicular Lymphoma and other hematological malignancies, Alk-4 translocation in lung, hematological and pediatric cancers. Other tests that are in the pipeline include Urovision (Abbott) for the detection of altered cells in Bladder Cancer, TFE-3 translocation in kidney tumors, EML-4 translocation in lung cancer, EWSR1, FLI1 translocations in pediatric tumors (Ewing's sarcoma and Rabdomyosarcoma), etc. The lab is in the process to undergo CAP certification to start accepting patient samples for diagnostics.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Clinical Support Services Intramural Research (ZID)
Project #
1ZIDBC011349-01
Application #
8158436
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2010
Total Cost
$318,811
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
Zip Code
Zhang, Chao; Yang, Andrew I; Vasconcelos, Lucas et al. (2014) Von hippel-lindau disease associated pulmonary carcinoid with cranial metastasis. J Clin Endocrinol Metab 99:2633-6
Sadri, Navid; Barroeta, Julieta; Pack, Svetlana D et al. (2014) Malignant round cell tumor of bone with EWSR1-NFATC2 gene fusion. Virchows Arch 465:233-9
Mamessier, Emilie; Song, Joo Y; Eberle, Franziska C et al. (2014) Early lesions of follicular lymphoma: a genetic perspective. Haematologica 99:481-8
Nicolae, A; Xi, L; Pittaluga, S et al. (2014) Frequent STAT5B mutations in ?? hepatosplenic T-cell lymphomas. Leukemia 28:2244-8
Arnold, Michael A; Ballester, Leomar Y; Pack, Svetlana D et al. (2014) Primary subcutaneous spindle cell Ewing sarcoma with strong S100 expression and EWSR1-FLI1 fusion: a case report. Pediatr Dev Pathol 17:302-7
Zhuang, Zhengping; Frerich, Jason M; Huntoon, Kristin et al. (2014) Tumor derived vasculogenesis in von Hippel-Lindau disease-associated tumors. Sci Rep 4:4102
Mardekian, Stacey K; Gandhe, Ashish; Miettinen, Markku et al. (2014) Two Cases of Spinal, Extraosseous, Intradural Ewing's sarcoma/Peripheral Neuroectodermal Tumor: Radiologic, Pathologic, and Molecular Analysis. J Clin Imaging Sci 4:6
Li, Hongzhen; Rodriguez-Canales, Jaime; Liu, Wenli et al. (2013) Deletion of the olfactomedin 4 gene is associated with progression of human prostate cancer. Am J Pathol 183:1329-38
Miettinen, Markku; Wang, Zengfeng; Sarlomo-Rikala, Maarit et al. (2013) ERG expression in epithelioid sarcoma: a diagnostic pitfall. Am J Surg Pathol 37:1580-5
Aung, Phyu P; Ballester, Leomar Y; Abdullaev, Zied et al. (2013) ER/PR positive epidermotropic primary cutaneous eccrine carcinoma as a cutaneous manifestation of MEN 2B. J Am Acad Dermatol 69:e310-2

Showing the most recent 10 out of 13 publications